The FDA Law Blog

JUNE 27, 2023

Walsh — Last fall, we blogged about the process FDA uses to review allegations of regulatory misconduct against device manufacturers, suggesting greater transparency on the FDA process was needed (see here ).

FDA 59

FDA Documentation Labelling Communication 59

Pharmafile

MARCH 21, 2023

It appears that the FDA is inclined to support Biogen’s amyotrophic lateral sclerosis (ALS) drug, tofersen, with documents released on Monday stressing the need for “regulatory flexibility” when assessing treatments for life threatening diseases such as ALS. read more

FDA 59

FDA Documentation Communication 59

The FDA Law Blog

JUNE 20, 2023

Mullen — On June 2, 2023, FDA issued the latest version of its guidance on Requests for Feedback and Meetings for Medical Device Submissions: The Q-Submission Program. The document provides minor updates on procedures, incorporating recent developments and experiences in how FDA interacts with industry.

FDA 45

FDA Documentation Communication 45

pharmaphorum

OCTOBER 4, 2022

On 27th September 2022, the Food and Drug Administration (FDA) issued its final guidance for industry and FDA staff clinical decision support (CDS) software, which has been anticipated since the Center for Devices and Radiological Health (CDRH) listed the guidance as a top priority for fiscal year 2022. Criteria for regulation.

FDA 105

FDA Documentation Labelling Communication 105

The FDA Law Blog

JULY 7, 2024

Unfortunately, the guidance for small entities recently published by FDA is little more than a summary digest of the multi-hundred-page final rule. However, the guidance provides no new information on how FDA expects laboratories to implement these new requirements.

Labelling 64

Labelling FDA Communication Documentation 64

The FDA Law Blog

OCTOBER 31, 2022

Lenz, Principal Medical Device Regulation Expert — FDA began the Software Precertification (Pre-Cert) pilot program in 2017 to evaluate an alternative approach to regulation of software as a medical device (SaMD) over the total product lifecycle (TPLC). As part of the pilot program, FDA included a Test Plan. By Adrienne R.

FDA 72

FDA Documentation Communication 72

Impact Pharmaceutical Services

MAY 4, 2022

In May of 2014 and February of 2019 , the FDA released final Guidance for Industry outlining the Agency’s policies and procedures regarding expedited development and review programs for new drugs and biologics intended to treat serious or life-threatening conditions. Image courtesy of qimono at pixabay.com.

FDA 52

FDA Documentation Communication 52

The FDA Law Blog

MARCH 7, 2023

If multiple people are reviewing and need to communicate changes it may be challenging to ensure all updates are incorporated. Lack of compatibility with cloud-based document sharing. Creation of unnecessary documents. There is no option to reference a document that has already been attached elsewhere in the submission.

Documentation 59

Documentation FDA Communication 59

Digital Pharmacist

NOVEMBER 21, 2022

Food and Drug Administration (FDA) announced its approval of the Boostrix vaccine, commonly known as Tdap (combination of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis) for immunization administration during the third trimester of pregnancy to prevent pertussis in infants younger than two months of age.

Communication 98

Communication Documentation Immunization Vaccines 98

The FDA Law Blog

OCTOBER 10, 2022

Javitt — On September 28, 2022, the FDA issued the long anticipated final Clinical Decision Support Software Guidance (CDS Guidance), which replaces the revised draft guidance document from 2019. FDA interprets the term “pattern” to mean “multiple, sequential, or repeated measurements of a signal or from a signal acquisition system.”

FDA 52

FDA Labelling Documentation Communication 52

The FDA Law Blog

JUNE 8, 2023

The pandemic had changed the way people live, work and communicate. FDA has begun to reintroduce in-person meetings. It is also noteworthy that in the March 27 announcement , FDA distinguished between teleconferences and videoconferences despite using the same online platform (e.g., However, not all changes are forever.

FDA 53

FDA Communication Documentation 53

The Checkup by Singlecare

APRIL 5, 2024

That’s because the Food and Drug Administration (FDA) has approved it for Type 2 diabetes , while weight management is technically an off-label treatment. Foxman recommends that every patient review their formulary to see how Ozempic is covered and communicate directly with their insurer for clarity on the specific requirements. “It’s

Insurance 78

Insurance Documentation Insurance Coverage FDA 78

The FDA Law Blog

NOVEMBER 15, 2022

User fees are fees that FDA collects from “companies that produce certain products, such as drugs and medical devices, and from some other entities, such as certain accreditation and certification bodies.” These fees supplement the annual funding Congress provides for FDA. These fees are negotiated by FDA and industry every five years.

FDA 59

FDA Documentation Communication 59

European Pharmaceutical Review

JULY 4, 2023

There are also numerous industry guidance documents for products manufactured for use in clinical trials and guidelines, some which are specific to advanced therapeutic drug products that must be consulted. Teams must also accept the variety of analytical procedures these regulatory agencies prefer.

Communication 98

Communication Chemotherapy Documentation Dosage 98

The Checkup by Singlecare

DECEMBER 1, 2022

These types of pharmacies act as the contact between the pharmaceutical company and regulatory agencies, such as the FDA. Assessing and communicating the regulatory guidelines for medication approval. Presenting documents to the appropriate regulatory agency and making changes as necessary .

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 98

The FDA Law Blog

MAY 11, 2023

government in the now-infamous (at least in FDA circles) Teva v. Other communications may suffice to show infringement, but carved-out labeling more accurately reflects an intent not to encourage infringement, reasons the Government, extensively citing Judge Prost’s Federal Circuit dissent. GSK skinny label case , the U.S.

Labelling 72

Labelling FDA Documentation Communication 72

The FDA Law Blog

FEBRUARY 28, 2023

Lenz, Principal Medical Device Regulation Expert — Since 2005, 510(k) submissions have been formatted according to FDA guidance Format for Traditional and Abbreviated 510(k)s. Several sections of the eSTAR templates have questions that walk through related guidance documents. By Adrienne R. Know Your Guidances.

Documentation 52

Documentation Labelling Communication FDA 52

The FDA Law Blog

FEBRUARY 5, 2024

Her expertise includes preparation and maintenance of licensing documentation, communications with state boards and government agencies, conducting research, and the preparation of associated licensing documentation and applications.

Controlled Substances 45

Controlled Substances Documentation Communication 45

Viseven

DECEMBER 4, 2024

It also requires documenting the entire process, from raw material sourcing to product launch. It ensures compliance The Food and Drug Administration (FDA) in the U.S. Process design should be based on solid evidence and include thorough documentation. The FDA suggests using measurable data to monitor performance accurately.

Documentation 52

Documentation Pharmaceutical Companies Pharmaceutical Companies FDA 52

ISPE

MARCH 16, 2023

The document provides specific guidance on the sampling and testing procedures for environmental monitoring, as well as the limits for particular and microbial contamination. Some of these challenges include for example regulatory compliance, quality control and effective communication between the original manufacturer and the CMO.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Documentation Compounding 98

European Pharmaceutical Review

MARCH 12, 2024

Regulatory bodies such as the US Food and Drug Administration (FDA) and European Medicines Agency (EMA) place great importance on data integrity in the pharmaceutical/life science industry. Good documentation practices. Joseph S Boakai (JSB): The three current trends are as follows: Increased scrutiny by regulatory bodies.

Documentation 98

Documentation Data Entry Communication Compounding 98

The FDA Law Blog

OCTOBER 10, 2023

By Philip Won & Véronique Li, Senior Medical Device Regulation Expert — As we recently blogged , FDA released three draft guidance documents to help enhance the predictability, consistency, and transparency of the 510(k) program. One of these documents focuses on “ Evidentiary Expectations for 510(k) Implant Devices.”

Documentation 45

Documentation FDA Labelling Communication 45

Viseven

NOVEMBER 17, 2022

Medical affairs in Pharma are often seen as a central agency that works within a healthcare company and prioritize communication among life science organizations, medical professionals, healthcare providers, and patients. Medical affairs definition uses clinical and scientific information to communicate the efficiency of a drug.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Documentation 52

DiversifyRx

JULY 11, 2024

Small Dispensers and the 6/12/2024 FDA Announcement Concerning DSCSA This week’s article on the recent DSCSA postponement comes from PRS Pharmacy Services. If the FDA or another regulator requests DSCSA transaction data, the DSCSA regulations give you up to 48 hours to respond. The original article can be found HERE.

Independent Pharmacies 52

Independent Pharmacies FDA Documentation CPhT 52

The FDA Law Blog

AUGUST 9, 2023

Two licensed pharmacists must directly communicate the transfer. As with other required controlled substance records, electronic records documenting EPCS transfers must be maintained for two years from the transfer date by both the transferring and receiving pharmacies. cannot be altered during the transmission.

Controlled Substances 52

Controlled Substances Documentation Communication 52

The FDA Law Blog

NOVEMBER 2, 2023

Lewis, Senior Regulatory Device & Biologics Expert — On October 20, 2023, FDA announced the availability of the final guidance authored by CBER titled “Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies.” Existing published VCS may be identified internally by FDA or externally by stakeholders.

FDA 59

FDA Packaging Documentation Labelling 59

ISPE

NOVEMBER 28, 2022

The Advancing Pharmaceutical Quality, Quality Management Maturity Program includes five guidance documents: Corrective Action and Preventive Action (CAPA) : ICH Q10 demonstrates defined requirements for a robust corrective action and preventive action system throughout the product lifecycle. Internal Communication. CAPA Effectiveness.

Documentation 52

Documentation Communication Pharmaceutical Companies Pharmaceutical Companies 52

The Checkup by Singlecare

DECEMBER 26, 2023

Yes, as of March 2020 , insulin is considered a biologic product by the FDA. Regulatory bodies such as the FDA conduct thorough tests to confirm that they meet safety, purity, and potency standards. The FDA Purple Book database can be a good resource to determine whether a biologic drug is interchangeable.

FDA 52

FDA Communication Documentation 52

The FDA Law Blog

OCTOBER 6, 2022

The standard practice is for FDA to engage with companies on an individual basis through formal meetings and deliver directed feedback to specific sponsor questions. OTP has spent years communicating industry-wide problems on an individual basis. At this time, they recommend developers follow ICH Q5e when assessing comparability.

Documentation 52

Documentation FDA Communication 52

Viseven

SEPTEMBER 6, 2024

Achieving effective communication between a healthcare specialist and a patient is impossible if data the healthcare provider relies on data that can be misunderstood, misinterpreted, and misused. If any piece of data is used after its documentation or creation, it’s crucial that it be attributed to the original source.

Health and Personal Care Stores 52

Health and Personal Care Stores Documentation Data Entry Pharmaceutical Companies 52

pharmaphorum

JANUARY 4, 2022

They also used direct communication, marketing materials, media and financial statements, models and other information to defraud potential investors, according to the complaint. She admitted using pharma company logos – including Pfizer – on Theranos documents sent to investors, even though they had not endorsed the technology.

Documentation 52

Documentation Communication FDA 52

The Checkup by Singlecare

MAY 1, 2024

The FDA has approved these devices for mild to moderate hearing loss. Necessary documentation and information Financial assistance programs may require proof of income. Other documentation they may require includes: Identification (driver’s license, passport, etc.)

Health and Personal Care Stores 85

Health and Personal Care Stores Insurance Insurance Coverage Communication 85

DiversifyRx

NOVEMBER 24, 2023

This record-keeping includes detailed documentation of the product’s history and movement through the supply chain. When regulators, such as the FDA, request information about a specific drug product, your pharmacy must be able to promptly provide the necessary traceability data. The DSCSA aims to streamline this recall process.

Independent Pharmacies 40

Independent Pharmacies Packaging Documentation FDA 40

Hospital Pharmacy Europe

JUNE 8, 2023

A lack of transparency The importance of setting the primary outcome prior to commencing a study and not deviating from the original protocol, was first highlighted in 1990 by Jay Siegel , a physician and research scientist working for the FDA in the US. Nevertheless, it is incumbent on trialists to communicate such changes.

Documentation 52

Documentation Communication Patient Care Hospitals 52

ISPE

JULY 19, 2023

and management communication strategy. This includes ensuring maturity levels for all operating model elements follow the five general maturity levels defined by the FDA: 1–Initial, 2–Developmental, 3–Defined, 4–Managed, and 5–Optimized. Is the vendors’ documentation complete in order to assess GxP risks and GxP compliance?

Documentation 98

Documentation FDA Labelling Communication 98

pharmaphorum

DECEMBER 6, 2022

Clinical trials are the engine for pharmaceutical innovation, but their means of capturing and communicating data are stuck in the past. In most cases, the EHRs and EDCs don’t communicate, so in order to share that data with trial organisers, staff members at medical centres must manually copy data between the EHR and an EDC.

Data Entry 98

Data Entry Communication Hospitals Documentation 98

The FDA Law Blog

FEBRUARY 27, 2023

Comment topics suggested by DEA include the following: Whether the rule should limit the issuance of prescriptions for controlled medications to FDA-approved indications contained in the labeling for those medications. The only schedule III-V narcotic drug that is currently approved by the FDA for OUD treatment is buprenorphine.

Controlled Substances 59

Controlled Substances FDA Documentation Labelling 59